Svb Wealth LLC Arbutus Biopharma Corp Transaction History
Svb Wealth LLC
- $2.41 Billion
- Q1 2025
A detailed history of Svb Wealth LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Svb Wealth LLC holds 1,719 shares of ABUS stock, worth $5,930. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,719Holding current value
$5,930% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
191Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$82.1 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$45.9 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$39.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$32.7 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$30.9 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $517M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...